Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
5 papers
Recent·Most cited
A. Glencer, K. Ramalingam, N. Schindler, H. Mori, P. Ghule, K. C. Lee, D. Nachmanson, A. Officer, O. Harismendy, J. L. Stein, G. Stein, D. Weaver, C. Yau, G. L. Hirst, M. J. Campbell, , A. D. Borowsky
This study identifies immune microenvironment features and myoepithelial continuity as key determinants of progression in high-risk DCIS.
bioRxiv · Dec 1, 2023 · PreprintCancer Biology
F. Faraji, S. I. Ramirez, L. Clubb, K. Sato, V. Burghi, T. S. Hoang, A. Officer, P. Y. Anguiano Quiroz, W. M. Galloway, Z. Mikulski, K. Medetgul-Ernar, P. Marangoni, K. B. Jones, A. A. Molinolo, K. Kim, , J. S. Gutkind
The paper identifies YAP-driven reprogramming of oral epithelial stem cells into tumor-initiating cells using single-cell multiomics, revealing conserved transcriptional programs linked to poor patient survival.
bioRxiv · Jul 24, 2023Cancer Biology
A. Semaan, V. Bernard, J. Wong, Y. Makino, D. Swartzlander, K. I. Rajapakshe, J. Lee, A. Officer, C. M. Schmidt, H. H. Wu, C. L. Scaife, K. E. Affolter, D. Nachmanson, M. A. Firpo, M. Yip-Schneider, , P. A. Guerrero
This study integrates genomic and transcriptomic analysis of intraductal papillary mucinous neoplasms (IPMNs) to identify molecular features associated with progression to high-grade lesions and cancer.
bioRxiv · Oct 14, 2022 · PreprintCancer Biology
A. Officer, A. M. Dempsey, L. M. Murrow, Z. Gartner, P. Tamayo, C. Yau, O. Harismendy
This study identifies changes in stromal-epithelial interactions between in situ and invasive breast cancer using gene expression profiling, finding significant ligand-receptor pairs associated with prognosis.
bioRxiv · Jul 30, 2022 · PreprintCancer Biology
A. Papadas, G. Deb, A. Officer, A. Cicala, C. Hope, P. Emmerich, J. Wiesner, A. Pagenkopf, G. Arauz, V. Bansal, K. Matkowskyj, D. A. Deming, K. Politi, S. Abrams, O. Harismendy, F. Asimakopoulos
The paper shows that stromal remodeling generates signals that regulate dendritic cell survival and activity, enhancing T-cell inflammation in the tumor microenvironment.
bioRxiv · Nov 10, 2021Immunology